|
|
1.
|
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial. MedStar authors:
Year: 2016
Citation: - Lancet. 387(10013):31-9, 2016 Jan 2.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Clinical Study
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Abizaid A, Christiansen EH, Eeckhout E, Escaned J, Garcia-Garcia HM, Haude M, Ince H, Kaiser C, Lemos PA, Lim ST, Neumann FJ, Toelg R, von Birgelen C, Waksman R, Wijns W
|
